Related Experiment Video
Updated: Aug 10, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Imaging acute renal failure with polyamine dendrimer-based MRI contrast agents
James W Dear1, Hisataka Kobayashi, Martin W Brechbiel
1Renal Diagnostics and Therapeutics Unit, NIDDK, Bethesda, Md 20892-1268, USA.
Abstract:
Acute renal failure (ARF) induced by sepsis has a high mortality but lacks effective treatments. To develop novel therapies we must diagnose renal injury early and accurately in septic patients and identify any additional insults such as nephrotoxic drugs and ischemia. In this short review we describe our experience using MRI with dendrimer-based contrast agents in mouse models of ARF. This technique can diagnose early renal injury before serum creatinine is elevated, distinguish different ARF etiologies, track drug therapy and predict outcome. As an ARF biomarker, MRI with dendrimer-based contrast is a promising technique deserving further development.
More Related Videos
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Magnetic Resonance Imaging
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies for Cardiovascular System IV: CMRI

